SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$3.72B
This Quarter Return
-1.14%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$5.44B
AUM Growth
-$36M
(-0.66%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
10.05%
Holding
1,994
New
353
Increased
482
Reduced
698
Closed
318
Top Buys
| 1 |
AT&T
T
|
+$94.2M |
| 2 |
Boeing
BA
|
+$20.6M |
| 3 |
Exxon Mobil
XOM
|
+$20.3M |
| 4 |
Li Auto
LI
|
+$17.1M |
| 5 |
Cintas
CTAS
|
+$17.1M |
Top Sells
| 1 |
T-Mobile US
TMUS
|
+$50.2M |
| 2 |
Emerson Electric
EMR
|
+$18.4M |
| 3 |
Altice USA
ATUS
|
+$18.2M |
| 4 |
Lockheed Martin
LMT
|
+$17.3M |
| 5 |
Moody's
MCO
|
+$15.7M |
Sector Composition
| 1 | Technology | 16.44% |
| 2 | Financials | 12.97% |
| 3 | Consumer Discretionary | 11.74% |
| 4 | Healthcare | 11.58% |
| 5 | Industrials | 11.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Aldeyra Therapeutics
ALDX
$333M
| $242K | ﹤0.01% |
27,531
-8,290
| -23% | -$72.9K |
|
1477
Collegium Pharmaceutical
COLL
$1.19B
| $241K | ﹤0.01% |
+12,200
| New | +$241K |
|
1478
Outlook Therapeutics
OTLK
$44.4M
| $241K | ﹤0.01% |
+5,555
| New | +$241K |
|
1479
CEL-SCI Corp
CVM
$66.6M
| $240K | ﹤0.01% |
+727
| New | +$240K |
|
1480
Atlanta Braves Holdings Series B
BATRK
$2.62B
| $239K | ﹤0.01% |
9,061
-16,101
| -64% | -$425K |
|
1481
Community Trust Bancorp
CTBI
$1.04B
| $238K | ﹤0.01% |
+5,650
| New | +$238K |
|
1482
Smith Micro Software
SMSI
$15.3M
| $238K | ﹤0.01% |
+6,148
| New | +$238K |
|
1483
BancFirst
BANF
$4.46B
| $237K | ﹤0.01% |
3,945
-6,002
| -60% | -$361K |
|
1484
Enanta Pharmaceuticals
ENTA
$178M
| $237K | ﹤0.01% |
4,169
-4,495
| -52% | -$256K |
|
|
TRTX
1485
TPG RE Finance Trust
TRTX
$744M
| $237K | ﹤0.01% |
19,135
-2,301
| -11% | -$28.5K |
|
|
CTLT
1486
DELISTED
CATALENT, INC.
CTLT
| $237K | ﹤0.01% |
1,779
-29,085
| -94% | -$3.87M |
|
1487
Avidity Biosciences
RNA
$5.97B
| $235K | ﹤0.01% |
+9,550
| New | +$235K |
|
|
NFH
1488
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $235K | ﹤0.01% |
+20,900
| New | +$235K |
|
1489
AYTU BioPharma
AYTU
$20.5M
| $233K | ﹤0.01% |
4,043
+1,302
| +48% | +$75K |
|
|
TVTY
1490
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $232K | ﹤0.01% |
+10,040
| New | +$232K |
|
|
RAVN
1491
DELISTED
Raven Industries Inc
RAVN
| $232K | ﹤0.01% |
4,023
-21,842
| -84% | -$1.26M |
|
1492
Protagonist Therapeutics
PTGX
$3.59B
| $231K | ﹤0.01% |
13,015
-21,605
| -62% | -$383K |
|
1493
MaxLinear
MXL
$1.37B
| $230K | ﹤0.01% |
4,673
-4,458
| -49% | -$219K |
|
1494
Relay Therapeutics
RLAY
$700M
| $230K | ﹤0.01% |
+7,300
| New | +$230K |
|
|
QUOT
1495
DELISTED
Quotient Technology Inc
QUOT
| $230K | ﹤0.01% |
39,500
+22,803
| +137% | +$133K |
|
|
CLR
1496
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $228K | ﹤0.01% |
+4,940
| New | +$228K |
|
|
ADAP
1497
Adaptimmune Therapeutics
ADAP
$13.5M
| $227K | ﹤0.01% |
43,960
-75,790
| -63% | -$391K |
|
1498
Milestone Pharmaceuticals
MIST
$145M
| $227K | ﹤0.01% |
39,802
-11,700
| -23% | -$66.7K |
|
1499
Resources Connection
RGP
$167M
| $227K | ﹤0.01% |
14,405
-10,515
| -42% | -$166K |
|
|
SAFE
1500
DELISTED
Safehold Inc.
SAFE
| $227K | ﹤0.01% |
+3,160
| New | +$227K |
|